Endothelial Dysfunction through Oxidatively Generated Epigenetic Mark in Respiratory Viral Infections

Area of Science:

• Pulmonary Medicine
• Vascular Biology
• Infectious Diseases

Background:

• Respiratory viral infections, including RSV, influenza, and SARS-CoV-2, pose significant health risks, especially for vulnerable populations.
• Current prevention strategies are limited by viral evolution and host immune responses, with no effective antiviral drugs available.
• Management focuses on supportive care, as respiratory failure, often linked to endothelial complications like edema, is the primary cause of mortality.

Purpose of the Study:

• To review the current understanding of pulmonary vascular endothelium's role in viral infection-induced respiratory distress.
• To explore the mechanisms by which viral infections alter endothelial function, including cytokine, growth factor, and epigenetic influences.
• To discuss emerging therapeutic strategies aimed at mitigating the impact of these endothelial changes.

Main Methods:

• Literature review of recent research on viral respiratory infections and pulmonary vascular endothelium.
• Analysis of the pathophysiology of endothelial dysfunction in respiratory viral infections.
• Synthesis of information on molecular mechanisms and potential therapeutic targets.

Main Results:

• The pulmonary vascular endothelium is critically involved in the pathology of severe respiratory viral infections.
• Viral infections trigger complex responses, including cytokine release and epigenetic changes, that compromise endothelial integrity and increase permeability.
• Endothelial dysfunction contributes significantly to edema and respiratory failure.

Conclusions:

• The pulmonary vascular endothelium is a key player in the severity of respiratory viral infections.
• Targeting endothelial pathways offers a promising avenue for novel therapeutic interventions.
• Further research into endothelial responses and treatments is essential to reduce disease burden.